Literature DB >> 2383894

Interleukin-4 receptors on human blood mononuclear cells.

C E Zuber1, J P Galizzi, N Harada, I Durand, J Banchereau.   

Abstract

We have studied regulation of the expression of the interleukin-4 receptor (IL-4R) on human blood mononuclear cells (PBMC) using both 125I-IL-4 binding assay and flow cytometric analysis of biotinylated IL-4 (B-IL-4) binding. PBMC express approximately 300 high-affinity IL-4R per cell (Kd = 25-100 pM). Activation of PBMC for 60-80 hr by phytohemagglutinin (PHA) or concanavalin A (Con A) results in a 2- to 4.5-fold increase of IL-4R number without alteration of IL-4R affinity for IL-4. Binding of B-IL-4 showed that IL-4R expression is upregulated on virtually all PHA-stimulated PBMC, whereas it mostly concerns larger cells among Con A-activated PBMC. Reculture of PHA-blasts with 1 nM IL-4 further upregulates IL-4R expression to a level approximately 10-fold higher than observed on freshly isolated PBMC. Interestingly, IL-4 is able to reinduce high IL-4R levels on cells that have been deprived of IL-4 for 20 hr and IL-2 is almost as efficient. Finally, SDS-PAGE analysis of IL-4-binding molecules on unstimulated, PHA- and PHA/IL-4-activated PBMC revealed the same three peptides of MW 140-130, 80-75, and 70-65 kDa, as shown on human cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383894     DOI: 10.1016/0008-8749(90)90209-a

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.

Authors:  M H Kaplan; C Daniel; U Schindler; M J Grusby
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

2.  Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HIV-1) infection.

Authors:  R Zambello; L Trentin; R Benetti; A Cipriani; C Crivellaro; P Cadrobbi; C Agostini; G Semenzato
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

3.  Inhibition of IL-4 receptor up-regulation on B cells by antisense oligodeoxynucleotide suppresses IL-4-induced human IgE production.

Authors:  K Ikizawa; K Kajiwara; T Koshio; N Matsuura; Y Yanagihara
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

4.  Oligoclonal activation of CD4+ T lymphocytes in posterior uveitis.

Authors:  E J Feron; V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

5.  Base and Covariate Population Pharmacokinetic Analyses of Dupilumab in Adolescents and Children ≥6 to <12 Years of Age Using Phase 3 Data.

Authors:  Pavel Kovalenko; Mohamed A Kamal; John D Davis; Nidal Huniti; Christine Xu; Ashish Bansal; Brad Shumel; A Thomas DiCioccio
Journal:  Clin Pharmacol Drug Dev       Date:  2021-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.